⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL632284 | 0.84 | FFAR3 (0.41) | — | |
| SCHEMBL6047432 | 0.74 | AKR1B1 (0.42) | — | |
| SCHEMBL128808 | 0.73 | FFAR3 (0.44) | — | |
| SCHEMBL5711158 | 0.73 | FFAR3 (0.44) | — | |
| SCHEMBL29065871 | 0.71 | FFAR3 (0.41) | — | |
| SCHEMBL8415864 | 0.69 | — | — | |
| SCHEMBL512768 | 0.67 | FFAR3 (0.38) | — | |
| SCHEMBL30203760 | 0.67 | — | — | |
| Propionic Acid SCHEMBL109638 | 0.66 | — | — | |
| SCHEMBL26864957 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105517548-B | Combination of MEK inhibitors and ERK inhibitors for the treatment of hyperproliferative disorders | 豪夫迈·罗氏有限公司 | 2020-01-21 | — | — | CN | disclosed |
| US-9532987-B2 | Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases | GENENTECH, INC. (US) | 2017-01-03 | — | — | US | disclosed |
| EP-3041471-A1 | COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES | F. Hoffmann-La Roche AG (CH) | 2016-07-13 | — | — | EP | disclosed |
| CN-105517548-A | Combination of MEK inhibitors and ERK inhibitors for the treatment of hyperproliferative disorders | HOFFMANN LA ROCHE | 2016-04-20 | — | — | CN | disclosed |
| US-20150111869-A1 | USE OF A COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES | GENENTECH, INC. (US) | 2015-04-23 | — | — | US | disclosed |
| WO-2015032840-A1 | COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2015-03-12 | — | — | WO | disclosed |